Chen J, Zhang K, Xu Y, Gao Y, Li C, Wang R, et al. The role of microRNA-26a in human cancer progression and clinical application. Tumour Biol. 2016;37(6):7095–108.

Article  CAS  PubMed  Google Scholar 

Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537–41.

Article  PubMed  PubMed Central  Google Scholar 

Moghbeli M. Genetic and molecular biology of breast cancer among Iranian patients. J Transl Med. 2019;17(1):218.

Article  PubMed  PubMed Central  Google Scholar 

Zangouei AS, Moghbeli M. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes Environ Off J Japan Environ Mutagen Soc. 2021;43(1):21.

CAS  Google Scholar 

Akhlaghipour I, Taghehchian N, Zangouei AS, Maharati A, Mahmoudian RA, Saburi E, et al. MicroRNA-377: A therapeutic and diagnostic tumor marker. Int J Biol Macromol. 2023;226:1226–35.

Article  CAS  PubMed  Google Scholar 

Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008;68(19):7846–54.

Article  CAS  PubMed  Google Scholar 

Hamidi AA, Taghehchian N, Basirat Z, Zangouei AS, Moghbeli M. MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer. Biomark Res. 2022;10(1):40.

Article  PubMed  PubMed Central  Google Scholar 

Maharati A, Moghbeli M. Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells. Cell Div. 2023;18(1):11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maharati A, Samsami Y, Latifi H, Tolue Ghasaban F, Moghbeli M. Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells. Cancer Cell Int. 2023;23(1):168.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moghbeli M. MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma. Pathol Res Pract. 2023;249: 154743.

Article  CAS  PubMed  Google Scholar 

Maharati A, Zanguei AS, Khalili-Tanha G, Moghbeli M. MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells. Cell Commun Signal. 2022;20(1):27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang P, Wu X, Wang X, Huang W, Feng Q. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. Oncotarget. 2016;7(28):43337–51.

Article  PubMed  PubMed Central  Google Scholar 

Jinushi T, Shibayama Y, Kinoshita I, Oizumi S, Jinushi M, Aota T, et al. Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. Cancer Med. 2014;3(6):1544–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni R, Huang Y, Wang J. miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer. Onco Targets Ther. 2015;8:2689–97.

CAS  PubMed  PubMed Central  Google Scholar 

Du Y, Shi X, Li J, Jia Y. MicroRNA-98-5p inhibits human mesangial cell proliferation and TNF-alpha and IL-6 secretion by targeting BTB and CNC homology 1. Exp Ther Med. 2021;22(6):1436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, et al. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget. 2012;3(11):1370–85.

Article  PubMed  PubMed Central  Google Scholar 

Sun HH, Sun PF, Liu WY. MiR-98-5p regulates myocardial differentiation of mesenchymal stem cells by targeting TBX5. Eur Rev Med Pharmacol Sci. 2018;22(22):7841–8.

PubMed  Google Scholar 

Xie L, Xu J. Role of MiR-98 and its underlying mechanisms in systemic Lupus Erythematosus. J Rheumatol. 2018;45(10):1397–405.

Article  CAS  PubMed  Google Scholar 

Ullah R, Yin Q, Snell AH, Wan L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol. 2022;85:123–54.

Article  CAS  PubMed  Google Scholar 

Navaei ZN, Khalili-Tanha G, Zangouei AS, Abbaszadegan MR, Moghbeli M. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. Oncol Res. 2021;29(4):235–50.

Article  PubMed  Google Scholar 

Maharati A, Moghbeli M. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell Commun Signal. 2023;21(1):201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao R, Wang H, Yang B. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway. Bioengineered. 2021;12(2):10596–607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM. The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res. 2008;14(20):6364–70.

Article  CAS  PubMed  Google Scholar 

Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911–2.

Article  CAS  PubMed  Google Scholar 

Du Y, Li Y, Lv H, Zhou S, Sun Z, Wang M. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(10):12252–9.

CAS  PubMed  PubMed Central  Google Scholar 

Guo C, Zhang M, Qian J, Li P, Guo L. Oncogenic long noncoding RNA Linc01287 promotes IGF1R expression by sponging mir-98 in breast cancer. Crit Rev Eukaryot Gene Expr. 2022;32(3):31–44.

Article  PubMed  Google Scholar 

Guo L, Bai Y, Ji S, Ma H. MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway. Int J Oncol. 2019;54(3):807–20.

CAS  PubMed  PubMed Central  Google Scholar 

Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 2010;28(1):92–8.

Article  CAS  PubMed  Google Scholar 

Emi Y, Kitamura K, Shikada Y, Kakeji Y, Takahashi I, Tsutsui S. Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis. Surgery. 2002;131(1 Suppl):S217–21.

Article  PubMed  Google Scholar 

Ahmad S, Gupta S, Kumar R, Varshney GC, Raghava GP. Herceptin resistance database for understanding mechanism of resistance in breast cancer patients. Sci Rep. 2014;4:4483.

Article  PubMed  PubMed Central  Google Scholar 

Spiliotaki M, Mavroudis D, Kokotsaki M, Vetsika EK, Stoupis I, Matikas A, et al. Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes. Mol Oncol. 2018;12(1):21–32.

Article  CAS